tiprankstipranks
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market

ADC Therapeutics (ADCT) Income Statement

Compare
337 Followers

ADC Therapeutics Income Statement

Last quarter (Q3 2024), ADC Therapeutics's total revenue was $18.02M, an increase of 24.31% from the same quarter last year. In Q3, ADC Therapeutics's net income was $-43.97M. See ADC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 69.56M$ 209.91M$ 33.92M$ 0.00$ 2.34M
Gross Profit
$ 67.03M$ 205.33M$ 32.52M$ -1.97M$ -105.20M
Operating Expenses
$ 233.01M$ 328.96M$ 294.24M$ 219.26M$ 121.74M
Depreciation and Amortization
$ 3.27M$ 2.39M$ 2.63M$ 1.97M$ 1.65M
EBITDA
$ -146.76M$ -108.06M$ -223.72M$ -219.26M$ -114.10M
Operating Income
$ -165.99M$ -123.63M$ -261.72M$ -219.26M$ -119.40M
Other Income/Expenses
$ -29.43M$ -33.56M$ 10.21M$ -26.70M$ 3.50M
Pretax Income
$ -195.42M$ -154.66M$ -251.50M$ -245.96M$ -115.90M
Net Income
$ -240.05M$ -155.80M$ -230.03M$ -246.29M$ -116.48M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.94$ -1.99$ -3.00$ -3.77$ -1.74
Diluted EPS
$ -2.94$ -1.99$ -3.00$ -3.77$ -1.74
Weighted Average Shares Outstanding
81.71M 78.15M 76.75M 65.41M 66.87M
Weighted Average Shares Outstanding (Diluted)
81.71M 78.15M 76.75M 65.41M 66.87M
Currency in USD

ADC Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis